Fitpan L Capsule SR is a combination medication containing Levosulpiride 75mg and Pantoprazole 40mg, designed to effectively manage gastrointestinal disorders. Levosulpiride is a prokinetic agent that enhances gastric motility by blocking dopamine receptors, thereby improving symptoms such as nausea, vomiting, bloating, and abdominal discomfort associated with delayed gastric emptying and functional dyspepsia. Pantoprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the stomach lining, providing relief from acid-related conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The sustained-release formulation ensures a gradual and prolonged therapeutic effect, improving patient compliance and symptom control. Fitpan L Capsule SR is typically prescribed for patients experiencing upper gastrointestinal symptoms due to acid hypersecretion and motility disturbances. It should be taken as directed by a healthcare professional, usually before meals, to maximize efficacy. Caution is advised in patients with known hypersensitivity to either component, and it is not recommended for use during pregnancy or lactation without medical supervision. Common side effects may include headache, dizziness, or mild gastrointestinal discomfort. Overall, Fitpan L Capsule SR offers a synergistic approach to managing complex gastric conditions by combining acid suppression with enhanced motility.